Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price hikes, among others.
For years a 10% annual price hike was fairly normal, but they've started coming down in recent years. This year's median price hike so far is only 4%, says Antonio Ciaccia, CEO of 46brooklyn.
"While it's early, if that number held throughout the year, that would make it the lowest median price increase in over a decade," says Ciaccia.
January is typically a popular time to raise prices on brand name drugs, but companies can raise them throughout the year. There could even be more later this month, he says.
As a bird flu outbreak continues to run rampant through US poultry farms, pushing eggs to...
The federal government has cancelled dozens of grants to study how to prevent new HIV infections...
